Maze Therapeutics’ consensus price target implies 120.5% upside potential, though the article notes this metric is not reliably informative. The near-term setup hinges on an upward trend in earnings estimate revisions, which could support upside for the stock despite skepticism on target-price methodology.
Maze Therapeutics’ consensus price target implies 120.5% upside potential, though the article notes this metric is not reliably informative. The near-term setup hinges on an upward trend in earnings estimate revisions, which could support upside for the stock despite skepticism on target-price methodology.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
